Innovate Vs. Nektar Therapeutics Industry Stock Comparison

Sell

8

VATE
Innovate

Last Price:

$4.65

Seasonality Move:

-7.55%

Buy

59

NKTR
Nektar Therapeutics

Last Price:

$25.80

Seasonality Move:

4.65%

Sell

8

Innovate (VATE) is a Sell

Is Innovate a Buy, Sell or Hold?

The current Innovate [VATE] share price is $4.54. The Score for VATE is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
VATE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Buy

59

Nektar Therapeutics (NKTR) is a Buy

Is Nektar Therapeutics a Buy, Sell or Hold?

The current Nektar Therapeutics [NKTR] share price is $25.72. The Score for NKTR is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
NKTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VATE Stock Price Chart

What is Innovate's stock price today?

The Innovate share price today is $4.54

The current trend is moderately bullish and VATE is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

The Nektar Therapeutics share price today is $25.72

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.

VATE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	1.25	Buy
Relative Strength Index (14 RSI):	37.72	Sell
Chaikin Money Flow:	-12175	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(5.01 - 5.81)	Sell
Bollinger Bands (100):	(5.12 - 6.84)	Sell

NKTR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.62	Buy
Relative Strength Index (14 RSI):	61.8	Buy
Chaikin Money Flow:	677331	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(22.56 - 25.12)	Buy
Bollinger Bands (100):	(8.21 - 22.19)	Buy

VATE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	5.06	Sell
20-day SMA:	5.41	Sell
50-day SMA:	5.42	Sell
200-day SMA:	6.65	Sell
8-day EMA:	4.69	Sell
20-day EMA:	3.58	Buy
50-day EMA:	1.98	Buy
200-day EMA:	0.59	Buy

NKTR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	23.11	Buy
20-day SMA:	23.68	Buy
50-day SMA:	20.19	Buy
200-day SMA:	15.03	Buy
8-day EMA:	23.52	Buy
20-day EMA:	23.17	Buy
50-day EMA:	20.66	Buy
200-day EMA:	16.42	Buy

Innovate Earnings Growth & VATE Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.01 per share, an increase this year of $2.16 per share, and a decrease next year of $1.84 per share.

Innovate Technical Analysis

	Jul 31	Aug 1	Aug 4	Aug 5	Aug 6	Aug 7	Aug 8	Aug 11	Aug 12	Aug 13
	Jul		Aug
	31	01	04	05	06	07	08	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

	Jul 31	Aug 1	Aug 4	Aug 5	Aug 6	Aug 7	Aug 8	Aug 11	Aug 12	Aug 13
	Jul		Aug
	31	01	04	05	06	07	08	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):